All In MedTech

FDA Clearance Tracker · P920047-S021

BLAZER II CARDIAC ABLATION CATHETHER, STEEROCATH-A CARDIAC ABLATION CATHETER,STEEROCATH-T CARDIAC ABLATION CATHETER

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 31, 2003 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Dec 31, 2003

Approved

Time to decision

58 days

Received Nov 3, 2003. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P920047-S021
Device name
BLAZER II CARDIAC ABLATION CATHETHER, STEEROCATH-A CARDIAC ABLATION CATHETER,STEEROCATH-T CARDIAC ABLATION CATHETER
Applicant location
St Paul, MN
Received
Nov 3, 2003
Decided
Dec 31, 2003
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P920047

Device type

Device class
Class III

Every decision under product code LPB

FDA's approval statement

As written in FDA's record.

APPROVAL FOR A STERILIZATION FACILITY LOCATED AT COSMED OF RHODE ISLAND, INC., COVENTRY, RHODE ISLAND.

Source documents

Other decisions for Boston Scientific Corp

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.